Log in | Jump |

Pharmababble

Biomedical investment and business development chatter





Things categorized as 'Sales/Marketing'


Archives

(preview-image)

One Man’s Trash: Novartis Buys Nektar’s Pulmonary Division for $115M


Posted on October 21st .
After one of the most spectacular failures in pharmaceutical marketing history (Pfizer/Nektar's Exubera; inhaled insulin), Read More →
(preview-image)

Do Gilead’s Earnings Spell The End of Large Sales Forces?


Posted on October 18th .
Gilead put up some pretty sweet numbers this quarter totally blowing away analyst expectations with both revenue and net income up over 25% each. Other high ...
(preview-image)

Pharma Employees Favor Obama


Posted on October 15th .
Results are In: Pharma Favors Obama (Via Pharma Marketing Blog.) Interesting results but the conclusion is a bit flawed. The poll asks to what ...
(preview-image)

Medical Schools Grades for Resistance to Pharma Marketing


Posted on June 3rd .
Image via Wikipedia Only 21 of 150 medical schools surveyed by the American Medical Student Association ...
(preview-image)

NanoHorizons Wins Second Funding Round


Posted on June 3rd .
Image via Wikipedia NanoHorizons announced that it has raised approximately $6.7 million in a second round of funding from Penn Venture Partners, L.P., ...

Paxil Back


Posted on June 1st .
Catchy video. Hat tip to PharmaGossip
(preview-image)

Icahn Steals The Future of Enzon Pharmaceuticals


Posted on May 7th .
Enzon Pharmaceuticals, on the reported urging of uber-investor Carl Icahn, will spin off a NewCo along with the majority of the company's core ...
(preview-image)

Sucampo and Takeda’s Amitiza Approved for IBS-c


Posted on April 30th .
On a disease sexiness scale from 0-100, chronic idiopathic constipation (CIC) and irritable bowel syndrome (IBS-c) are close to rounding out the bottom of ...
(preview-image)

Elixir Hoping to Cash In On Sirtuins Too After GSK / Sirtris Deal


Posted on April 28th .
For the first time in almost 10 months, and not surprisingly, coming on the heels of the GSK / Sirtris buyout that occurred ...

Biotech/Pharma Competitive Intelligence


Posted on April 24th .
Introduction A significant chunk of my job in business development entails competitive intelligence and I've found the lack of biotech/pharmaceutical specific guide in this area a ...
(preview-image)

Microbia Changes Name to Ironwood Pharmaceuticals


Posted on April 7th .
I wonder how much they paid for this marketing advice. It sounds like a golf course management company.